The major economically important tick‐borne diseases of cattle are theileriosis, babesiosis, anaplasmosis, and cowdriosis. Culture‐derived attenuated schizonts of Theileria annulata have proved to be safe for all types of cattle and they protect against tick‐borne theileriosis. T. parva was also successfully grown in vitro; however, inoculation of cattle with allogeneic schizont‐infected cells resulted in rejection and destruction of the parasites together with the host cells. The number of schizont‐infected cells needed for immunization is greater than for T. annulata theileriosis. Culture‐propagated Babesia bovis and B. bigemina were used for large scale vaccination in the field. An avirulent population of Babesia spp. was obtained by in vitro cloning; inoculation of cattle did not induce clinical babesiosis, but produced specific antibodies. Culture‐derived exoantigens of Babesia spp. proved to be completely safe for cattle, however, they conferred less protection than live parasites. Cell‐cultured Cowdria ruminantium was highly infective for susceptible animals but, attenuated in vitro, could offer a potential source for vaccination. Anaplasma marginale, successfully grown in tick cell culture, may be developed for vaccines. Factors that should be considered in the developing of vaccines against tick‐borne diseases include: the protective immune response to the pathogenic parasite developmental stages, virulence, immunological strain differences, and antigenic variations in cattle and in culture.